PA
ACI icon

PharVision Advisers’s Albertsons Companies ACI Stock Holding History

PharVision Advisers’s Portfolio ACI Stock Details ACI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,323
Closed -$332K – 102
2025
Q4 		$332K Sell
19,323
-1,214
-6% -$21.6K 0.17% 225
2025
Q3 		$360K Buy
+20,537
New +$403K 0.2% 130

Other funds holding ACI

CCM
Cerberus Capital Management New York $2.65B AUM 20.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

PharVision Advisers's ACI Position: Q1 2026 in Review

PharVision Advisers sold out of Albertsons Companies (ACI) in Q1 2026, closing a stake of 19,323 shares — an estimated $332K sold.

PharVision Advisers first reported a position in ACI in Q3 2025 and held it in 2 quarters. The position peaked at $360K in Q3 2025. 437 funds tracked by Wall St. Rank hold ACI as of Q1 2026.

  • PharVision Advisers reported no remaining Albertsons Companies position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 19,323 Albertsons Companies shares in Q1 2026, an estimated $332K.
  • PharVision Advisers first reported a position in Albertsons Companies in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's Albertsons Companies position peaked at $360K in Q3 2025.
  • 437 funds tracked by Wall St. Rank held Albertsons Companies as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.